VERGELLI, CLAUDIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.780
EU - Europa 4.233
AS - Asia 1.803
SA - Sud America 180
AF - Africa 37
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.067
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.758
PL - Polonia 1.876
RU - Federazione Russa 1.097
HK - Hong Kong 542
SG - Singapore 462
CN - Cina 393
IT - Italia 286
SE - Svezia 244
IE - Irlanda 242
KR - Corea 183
BR - Brasile 155
DE - Germania 119
GB - Regno Unito 102
UA - Ucraina 80
FI - Finlandia 77
VN - Vietnam 57
IN - India 52
ID - Indonesia 34
AU - Australia 32
FR - Francia 32
JO - Giordania 25
BE - Belgio 24
NL - Olanda 20
CA - Canada 15
ES - Italia 15
CI - Costa d'Avorio 14
TR - Turchia 14
JP - Giappone 9
EC - Ecuador 7
EG - Egitto 6
ZA - Sudafrica 6
AR - Argentina 5
MX - Messico 5
CH - Svizzera 4
IQ - Iraq 4
PY - Paraguay 4
SC - Seychelles 4
LV - Lettonia 3
PE - Perù 3
PK - Pakistan 3
RO - Romania 3
SA - Arabia Saudita 3
TN - Tunisia 3
UZ - Uzbekistan 3
BD - Bangladesh 2
BY - Bielorussia 2
DK - Danimarca 2
KZ - Kazakistan 2
PH - Filippine 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
BJ - Benin 1
BO - Bolivia 1
CL - Cile 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EU - Europa 1
GR - Grecia 1
IR - Iran 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MK - Macedonia 1
MM - Myanmar 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
SO - Somalia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 11.067
Salva come PNG Salva come JPEG
Città #
Warsaw 1.873
Santa Clara 1.206
Hong Kong 489
Fairfield 445
Ashburn 351
Singapore 298
Chandler 289
Dublin 241
Seattle 220
Seoul 180
Cambridge 178
Woodbridge 177
Houston 156
Ann Arbor 144
Wilmington 134
Jacksonville 128
Beijing 125
Florence 112
Buffalo 103
Hefei 95
Altamura 88
Lawrence 83
Los Angeles 76
Princeton 71
Dallas 58
Boston 41
Boardman 40
Mumbai 39
Moscow 38
Medford 37
Munich 37
Jakarta 33
Melbourne 31
Dong Ket 27
Shanghai 27
San Diego 26
New York 24
Brussels 23
London 23
Paris 20
Clifton 16
Kent 16
Council Bluffs 15
Abidjan 14
Barcelona 13
Turku 13
Hillsboro 12
Phoenix 12
Redondo Beach 12
Helsinki 11
Ho Chi Minh City 11
Norwalk 10
West Jordan 10
Chicago 9
Izmir 9
São Paulo 9
Yubileyny 9
Brooklyn 8
Groningen 8
Lappeenranta 8
Milan 8
Tokyo 8
Belo Horizonte 7
Falls Church 7
Frankfurt Am Main 7
Toronto 7
Curitiba 6
Frankfurt am Main 6
Fuzhou 6
Gavirate 5
San Jose 5
Teresópolis 5
Andover 4
Cairo 4
Guayaquil 4
Napoli 4
North Charleston 4
Philadelphia 4
Rio de Janeiro 4
Rome 4
San Francisco 4
Secaucus 4
Tampa 4
Tappahannock 4
The Dalles 4
Amsterdam 3
Auburn Hills 3
Baghdad 3
Bern 3
Denver 3
Elk Grove Village 3
Esslingen am Neckar 3
Fortaleza 3
Hanoi 3
Johannesburg 3
Menlo Park 3
Misano Adriatico 3
Montreal 3
Porto Alegre 3
Pune 3
Totale 8.185
Salva come PNG Salva come JPEG
Nome #
[(3-chlorophenyl)piperazinylpropyl]pyridazinones and analogues as potent antinociceptive agents 351
Synthesis, HPLC enantioresolution and X-ray analysis of a new series of C5-methyl pyridazines as N-formyl peptide receptor (FPR) agonists 308
Synthesis and analytical characterization of new thiazol-2-(3H)-ones as human neutrophil elastase (HNE) inhibitors 300
Isoxazolo-5(2H)-one: a new scaffold for potent human neutrophil elastase (HNE) inhibitors 290
Further studies on 2-arylacetamide pyridazin-3(2H)-ones: design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists. 273
Identification of a new pyrazolo[1,5-a]quinazoline ligand highly affine to γ-aminobutyric type A (GABAA) receptor subtype with anxiolytic-like and antihyperalgesic activity 261
Synthesis and evaluation as PDE4 inhibitors of pyrimidine-2,4-dione derivatives 259
Design, synthesis and evaluation of N-benzoylindazole derivatives and analogues as inhibitors of human neutrophil elastase 258
Synthesis and evaluation as antitubercular agents of 5-arylethenyl and 5-(hetero)aryl-3-isoxazolecarboxylate 253
Synthesis and pharmacological evaluation of new pyridazin-based thioderivatives as formyl peptide receptor (FPR) agonists 250
α2 Adrenoceptor: a Target for Neuropathic Pain Treatment 245
Synthesis, enantioresolution and activity profile of chiral 6-methyl-2,4-disubstituted pyridazin-3(2H)-ones as potent N-formyl peptide receptor agonists. 230
Synthesis of five and six-membered heterocycles bearing an arylpiperazinylalkyl side chain as orally active antinociceptive agents 223
Synthesis and pharmacological evaluation of novel GABAA subtype receptor ligands with potential anxiolytic-like and anti-hyperlagesic effect 220
2-Arylacetamido-4-phenylamino-5-substituted pyridazinones as formyl peptide receptors agonists. 220
New pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4-(3H)-ones fluoroderivatives as human A1 adenosine receptor ligands 219
Optimization of N-benzoylindazole derivatives as inhibitors of human neutrophil elastase 218
Synthesis and pharmacological evaluation of indole derivatives as deaza analogues of potent human neutrophil elastase inhibitors 204
Synthesis of five and six-membered N-phenylacetamido substituted heterocycles as formyl peptide receptor agonists 193
Further studies on pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as potent and selective human A1 adenosine receptor antagonists. 181
1H-pyrrolo[2,3-b]pyridine: a new scaffold for human neutrophil elastase (HNE) inhibitors 180
Synthesis, biological evaluation, and molecular modelling studies of potent human neutrophil elastase (HNE) inhibitors 177
Synthesis of New GABAA Receptor Modulator with Pyrazolo[1,5-a]quinazoline (PQ) Scaffold 175
Synthesis of pyrrolo[2,3-d]pyridazinones as potent, subtype selective PDE4 inhibitors 172
Further modifications of 1H-pyrrolo[2,3-b]pyridine derivatives as inhibitors of human neutrophil elastase 168
4-Amino-5-substituted-3(2H)-pyridazinones as orally active antinociceptive agents: synthesis and studies on the mechanism of action 166
Cinnoline derivatives as human neutrophil elastase inhibitors 163
Effects of the neutrophil elastase inhibitor EL-17 in rat adjuvant-induced arthritis. 162
SELECTIVE ACAT INHIBITORS AS PROMISING ANTIHYPERLIPIDEMIC, ANTIATHEROSCLEROTIC AND ANTI-ALZHEIMER DRUGS 158
ISOXAZOLO[3,4-D]PYRIDAZINONES AND ANALOGUES AS LEISHMANIA MEXICANA PDE INHIBITORS 158
4-AMINO-3(2H)-PYRIDAZINONES BEARING ARYLPIPERAZINYLALKYL GROUPS AND RELATED COMPOUNDS: SYNTHESIS AND ANTINOCICEPTIVE ACTIVITY 157
NOVEL 3-ARYLAMINO- AND 3-CYCLOALKYLAMINO-5,6-DIPHENYLPYRIDAZINES ACTIVE AS ACAT INHIBITORS 153
Arylpiperazinylalkylpyridazinones and analogues as potent and orally active antinociceptive agents: synthesis and studies on mechanism of action 151
6-Methyl-2,4-disubstituted pyridazin-3(2H)-ones: a novel class of small-molecule agonists for formyl peptide receptors. 147
1,5,6,7-Tetrahydro-4H-indazol-4-ones as human neutrophil elastase (HNE) inhibitors 146
New 3-unsubstituted Isoxazolones as Potent Human Neutrophil Elastase Inhibitors: Synthesis and Molecular Dynamic Simulation 144
Functionalized pyrazoles and pyrazolo[3,4-d]pyridazinones: synthesis and evaluation of their phosphodiesterase 4 inhibitory activity 143
4-amino-5-vinyl-3(2H)-pyridazinones and analogues as potent antinociceptive agents: synthesis, SARs, and preliminary studies on the mechanism of action 141
New pyrazolo[1',5':1,6]pyridazin-4(3H)-ones as potent and selective PDE5 inhibitors 138
Protective and Pain-Killer Effects of AMC3, a Novel N-Formyl Peptide Receptors (FPRs) Modulator, in Experimental Models of Rheumatoid Arthritis 137
AIRWAY RELAXANT AND ANTI-INFLAMMATORY PROPERTIES OF A PDE 4 INHIBITOR WITH LOW AFFINITY FOR THE HIGH-AFFINITY ROLIPRAM BINDING SITE 137
Synthesis, biological evaluation, molecular modeling, and structural analysis of new pyrazole and pyrazolone derivatives as N-formyl peptide receptors agonists 132
Exploration of Nitrogen Heterocycle Scaffolds for the Development of Potent Human Neutrophil Elastase Inhibitors 127
'Proximity frequencies' a new parameter to evaluate the profile of GABAAR modulators 126
Novel formyl peptide receptor (FPR) agonists with pyridinone and pyrimidindione scaffolds that are potentially useful for the treatment of rheumatoid arthritis 126
New 3,6-disubstituted pyrazolo[1,5-a]quinazolines as ligands to GABAA receptor subtype 125
Pyrazolo[1,5-a]quinazoline scaffold as 5-deaza analogue of pyrazolo[5,1-c][1,2,4]benzotriazine system: synthesis of new derivatives, biological activity on GABAA receptor subtype and molecular dynamic study 120
PDE5 Inhibitors and their applications 119
Further studies on arylpiperazinyl alkyl pyridazinones: discovery of an exceptionally potent, orally active, antinociceptive agent in thermally induced pain. 118
Pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as selective human A1 adenosine receptor ligands 115
4-amino-5-vinyl-3(2H)-pyridazinones and related compounds: synthesis and evaluation of antinociceptive activity 112
SYNTHESIS AND EVALUATION OF SOME PYRAZOLO[3,4-D]PYRIDAZINONES AND ANALOGUES AS PDE5 INHIBITORS POTENTIALLY USEFUL AS PERIPHERAL VASODILATOR 111
Novel Sulfonamide Analogs of Sivelestat as Potent Human Neutrophil Elastase Inhibitors 107
4,5-Dihydro-5-Oxo-Pyrazolo[1,5-a]Thieno[2,3-c]Pyrimidine: A Novel Scaffold Containing Thiophene Ring. Chemical Reactivity and In Silico Studies to Predict the Profile to GABAA Receptor Subtype 105
Ligand Growing Experiments Suggested 4-amino and 4-ureido pyridazin-3(2H)-one as Novel Scaffold for FABP4 Inhibition 101
Preparation of pyridazin-3(2H)-ones and their use as PDE4 inhibitors 99
New quinoline-based PDE4 inhibitors through GSK-256066 fragment-based elaboration 98
preparation of pyridazin-3(2H)-ones as phosphodiesterase 4 (PDE4) inhibitors 98
Alpha-2-agonist as analgesic agents 97
Ebselen analogues with dual human neutrophil elastase (HNE) inhibitory and antiradical activity 93
Synthesis and evaluation of novel pyrrolo[2,3-d] and thieno[2,3-d]pyridazinones as in vitro antiproliferative agents 93
Preparation of pyridazin-3(2H)-ones as phosphodiesterase 4 (PDE4) inhibitors 93
NEW SYNTHESIS OF DIFFERENTLY FUSED PYRIDAZINONQUINOLINES 91
Optimization of 4-amino-pyridazin-3(2H)-one as a valid core scaffold for FABP4 inhibitors 90
Novel pyrazolopyrimidopyridazinones with potent and selective phosphodiesterase 5 (PDE5) inhibitory activity agents as potential agents for treatment of erectile dysfunction 90
GABAA receptor modulators with a pyrazolo[1,5-a]quinazoline core: synthesis, molecular modelling studies and electrophysiological assay 88
Molecular manipulation of the 1,5,6,7-tetrahydro-4 H -indazol-4-one scaffold to obtain new human neutrophil elastase (HNE) inhibitors 87
Synthesis and inverse virtual screening of new bi-cyclic structures towards cancer-relevant cellular targets 75
Pyridinone Derivatives as Interesting Formyl Peptide Receptor (FPR) Agonists for the Treatment of Rheumatoid Arthritis 73
Pyridazin-3(2H)-one derivatives as novel PDE IV inhibitors 68
Polynitrogen Bicyclic and Tricyclic Compounds as PDE4 Inhibitors 50
Totale 11.256
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.541
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.541
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021757 0 0 0 0 59 123 70 82 126 178 46 73
2021/2022508 16 34 40 17 17 32 17 36 20 39 121 119
2022/20231.232 123 271 47 102 99 207 153 65 99 5 42 19
2023/2024405 12 48 81 22 22 54 12 96 8 27 16 7
2024/20253.470 123 324 173 470 1.000 467 63 161 395 76 94 124
2025/20261.498 365 514 299 192 128 0 0 0 0 0 0 0
Totale 11.256